End-of-day quote
Thailand S.E.
06:00:00 2024-05-30 pm EDT
|
5-day change
|
1st Jan Change
|
1.28
THB
|
+0.79%
|
|
-0.78%
|
-9.86%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
765.7
|
624.3
|
677.3
|
1,201
|
960
|
836.3
|
Enterprise Value (EV)
1 |
1,115
|
964.9
|
883.8
|
1,525
|
1,319
|
1,211
|
P/E ratio
|
32
x
|
22.4
x
|
12.2
x
|
20.9
x
|
16.1
x
|
27.2
x
|
Yield
|
3.08%
|
3.77%
|
4.35%
|
2.45%
|
4.91%
|
2.11%
|
Capitalization / Revenue
|
0.67
x
|
0.59
x
|
0.68
x
|
1.02
x
|
0.77
x
|
0.71
x
|
EV / Revenue
|
0.98
x
|
0.91
x
|
0.89
x
|
1.29
x
|
1.06
x
|
1.03
x
|
EV / EBITDA
|
12
x
|
9.93
x
|
7.75
x
|
12.3
x
|
10.5
x
|
10.7
x
|
EV / FCF
|
-39
x
|
30.1
x
|
7.27
x
|
-15.7
x
|
-26.4
x
|
13.2
x
|
FCF Yield
|
-2.56%
|
3.33%
|
13.8%
|
-6.36%
|
-3.79%
|
7.6%
|
Price to Book
|
1.04
x
|
0.84
x
|
0.88
x
|
1.5
x
|
1.16
x
|
1.02
x
|
Nbr of stocks (in thousands)
|
588,965
|
588,965
|
588,965
|
588,965
|
588,965
|
588,965
|
Reference price
2 |
1.300
|
1.060
|
1.150
|
2.040
|
1.630
|
1.420
|
Announcement Date
|
2/26/19
|
2/27/20
|
2/24/21
|
2/24/22
|
2/28/23
|
2/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,136
|
1,059
|
989.2
|
1,180
|
1,242
|
1,178
|
EBITDA
1 |
92.71
|
97.18
|
114
|
124.3
|
125.7
|
113
|
EBIT
1 |
38.28
|
39.13
|
53.09
|
59.96
|
57.71
|
42.64
|
Operating Margin
|
3.37%
|
3.7%
|
5.37%
|
5.08%
|
4.65%
|
3.62%
|
Earnings before Tax (EBT)
1 |
25.02
|
25.73
|
50.86
|
63.15
|
63.97
|
37.83
|
Net income
1 |
23.93
|
27.94
|
55.63
|
57.39
|
59.53
|
30.69
|
Net margin
|
2.11%
|
2.64%
|
5.62%
|
4.86%
|
4.79%
|
2.6%
|
EPS
2 |
0.0406
|
0.0474
|
0.0945
|
0.0974
|
0.1011
|
0.0521
|
Free Cash Flow
1 |
-28.56
|
32.1
|
121.5
|
-96.98
|
-50.06
|
92.05
|
FCF margin
|
-2.51%
|
3.03%
|
12.29%
|
-8.22%
|
-4.03%
|
7.81%
|
FCF Conversion (EBITDA)
|
-
|
33.03%
|
106.63%
|
-
|
-
|
81.47%
|
FCF Conversion (Net income)
|
-
|
114.88%
|
218.48%
|
-
|
-
|
299.9%
|
Dividend per Share
2 |
0.0400
|
0.0400
|
0.0500
|
0.0500
|
0.0800
|
0.0300
|
Announcement Date
|
2/26/19
|
2/27/20
|
2/24/21
|
2/24/22
|
2/28/23
|
2/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
349
|
341
|
206
|
324
|
359
|
374
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.768
x
|
3.505
x
|
1.811
x
|
2.604
x
|
2.858
x
|
3.313
x
|
Free Cash Flow
1 |
-28.6
|
32.1
|
122
|
-97
|
-50.1
|
92
|
ROE (net income / shareholders' equity)
|
3.25%
|
3.78%
|
7.34%
|
7.3%
|
7.24%
|
3.76%
|
ROA (Net income/ Total Assets)
|
1.86%
|
1.91%
|
2.73%
|
2.94%
|
2.58%
|
1.88%
|
Assets
1 |
1,285
|
1,465
|
2,037
|
1,951
|
2,304
|
1,634
|
Book Value Per Share
2 |
1.250
|
1.260
|
1.310
|
1.360
|
1.410
|
1.390
|
Cash Flow per Share
2 |
0.0100
|
0.0200
|
0.0300
|
0.0200
|
0.0300
|
0.0900
|
Capex
1 |
25.8
|
36.3
|
25.9
|
95.7
|
124
|
95
|
Capex / Sales
|
2.27%
|
3.43%
|
2.61%
|
8.11%
|
9.95%
|
8.06%
|
Announcement Date
|
2/26/19
|
2/27/20
|
2/24/21
|
2/24/22
|
2/28/23
|
2/28/24
|
|
1st Jan change
|
Capi.
|
---|
| -9.86% | 20.47M | | +17.07% | 66.31B | | -0.29% | 48.46B | | +21.61% | 43.27B | | +26.72% | 27.41B | | +9.25% | 19.26B | | -2.14% | 16.61B | | +9.75% | 16.58B | | -15.01% | 14.41B | | -30.22% | 14.02B |
Other Specialty Chemicals
|